Samithamby Jeyaseelan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samithamby Jeyaseelan has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Shanshan Cai
Center for Lung Biology and Disease, Louisiana State University , Baton Rouge, LA
18 shared publicationsSanjay Batra
14 shared publicationsLiliang Jin
Center for Lung Biology and Disease, Louisiana State University (LSU) School of Veterinary Medicine, Baton Rouge, LA, United States
11 shared publicationsGayathriy Balamayooran
9 shared publicationsLaxman Ghimire
Center for Lung Biology and Disease, Louisiana State University , Baton Rouge, LA
5 shared publications- Laxman Ghimire
Institute of Agriculture and Animal Science (IAAS), Tribhuvan University, Chitwan
5 shared publications
Latest Publications
- 10 October 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (1)
NLRC4 deficiency improves host protection during sepsis by regulating macrophage and T-cell responses
Sepsis followed by multiple organ failure is a leading cause of death in noncoronary intensive care units. While the NLRC4 inflammasome has been shown to play a crucial role in the innate immune response, the role of NLRC4 in sepsis remains unclear. Here, we used NLRC4 gene–deficient mice to explore its role in cecal ligation and puncture (CLP)–induced polymicrobial sepsis. Survival, bacterial clearance in the lung and extrapulmonary organs, and leukocyte influx to the peritoneum were determined. Chemokines and cytokines in the peritoneal fluid (PF) were quantified using ELISA. Mice were co-housed to compare the gut microbiota’s effect on bacterial burden following sepsis. Here, we report that NLRC4 deficiency improves host survival and bacterial clearance in mice with CLP-induced sepsis. Nlrc4−/− mice displayed reduced numbers of total leukocytes in the PF, including neutrophils compared to wild-type (WT) mice at 12 and 24 h post-CLP, although the recruitment of macrophages in NLRC4 knockout mice was higher at 12 h. Nlrc4−/− mice displayed lower levels of cytokines and chemokines in PF following sepsis. Co-housing of WT and Nlrc4−/− mice suggests that NLRC4 regulates host defense in CLP-induced sepsis independently of gut microbiota. Depletion of macrophages demonstrated that NLRC4 deficiency protects macrophages from sepsis-induced immune dysfunction. Moreover, we observed higher CD4+, CD8+, IFN-γ+CD8+, and NK cell subsets in the spleen and lower level of apoptosis of spleen cells of NLRC4-deficient mice after sepsis. Overall, these findings identify that NLRC4 activation has a detrimental role in sepsis through modulating macrophages and T-cell responses.
- 10 October 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (1)
NLRC4 deficiency improves host protection during sepsis by regulating macrophage and T-cell responses
Sepsis followed by multiple organ failure is a leading cause of death in noncoronary intensive care units. While the NLRC4 inflammasome has been shown to play a crucial role in the innate immune response, the role of NLRC4 in sepsis remains unclear. Here, we used NLRC4 gene–deficient mice to explore its role in cecal ligation and puncture (CLP)–induced polymicrobial sepsis. Survival, bacterial clearance in the lung and extrapulmonary organs, and leukocyte influx to the peritoneum were determined. Chemokines and cytokines in the peritoneal fluid (PF) were quantified using ELISA. Mice were co-housed to compare the gut microbiota’s effect on bacterial burden following sepsis. Here, we report that NLRC4 deficiency improves host survival and bacterial clearance in mice with CLP-induced sepsis. Nlrc4−/− mice displayed reduced numbers of total leukocytes in the PF, including neutrophils compared to wild-type (WT) mice at 12 and 24 h post-CLP, although the recruitment of macrophages in NLRC4 knockout mice was higher at 12 h. Nlrc4−/− mice displayed lower levels of cytokines and chemokines in PF following sepsis. Co-housing of WT and Nlrc4−/− mice suggests that NLRC4 regulates host defense in CLP-induced sepsis independently of gut microbiota. Depletion of macrophages demonstrated that NLRC4 deficiency protects macrophages from sepsis-induced immune dysfunction. Moreover, we observed higher CD4+, CD8+, IFN-γ+CD8+, and NK cell subsets in the spleen and lower level of apoptosis of spleen cells of NLRC4-deficient mice after sepsis. Overall, these findings identify that NLRC4 activation has a detrimental role in sepsis through modulating macrophages and T-cell responses.
- 2 October 2025
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 49 (11) , 2427-2435
Alcohol‐induced susceptibility to pulmonary bacterial infections: A narrative review
Alcohol intake is widely accepted in diverse cultures around the world, although heavy and prolonged consumption can be harmful. Alcohol influences multiple organs through interorgan and intercellular signaling cascades. The common health conditions associated with alcohol use disorder (AUD) are pancreatitis, liver cirrhosis, neuropathies, cardiomyopathies, and dementia. By virtue of its anatomical orientation and function, the lung continually encounters microbes, and this can be exacerbated by excessive alcohol consumption. Alcohol abuse is a well‐known risk factor for bacterial infection in the lung. Increased susceptibility to bacterial pneumonia is caused by impaired immune responses in individuals with AUD. The key cells to defend against pulmonary infections are innate immune cells, including alveolar macrophages, neutrophils, and adaptive immune cells, such as T and B cells. This review highlights recent advances illuminating the roles of innate immune responses in bacterial pneumonia and the effects of alcohol in bacterial pneumonia. Understanding the molecular mechanisms associated with innate immunity in the lung is essential for developing effective strategies to control pneumonia and alcohol‐mediated immunosuppression.
- 2 October 2025
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 49 (11) , 2427-2435
Alcohol‐induced susceptibility to pulmonary bacterial infections: A narrative review
Alcohol intake is widely accepted in diverse cultures around the world, although heavy and prolonged consumption can be harmful. Alcohol influences multiple organs through interorgan and intercellular signaling cascades. The common health conditions associated with alcohol use disorder (AUD) are pancreatitis, liver cirrhosis, neuropathies, cardiomyopathies, and dementia. By virtue of its anatomical orientation and function, the lung continually encounters microbes, and this can be exacerbated by excessive alcohol consumption. Alcohol abuse is a well‐known risk factor for bacterial infection in the lung. Increased susceptibility to bacterial pneumonia is caused by impaired immune responses in individuals with AUD. The key cells to defend against pulmonary infections are innate immune cells, including alveolar macrophages, neutrophils, and adaptive immune cells, such as T and B cells. This review highlights recent advances illuminating the roles of innate immune responses in bacterial pneumonia and the effects of alcohol in bacterial pneumonia. Understanding the molecular mechanisms associated with innate immunity in the lung is essential for developing effective strategies to control pneumonia and alcohol‐mediated immunosuppression.
- 8 August 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 214 (11) , 3043-3054
CXCL1 augments host defense against Legionella pneumophila through the IL-18–IFN-γ axis and neutrophil homeostasis
Legionella pneumophila causes severe pneumonia, resulting in acute lung injury. L. pneumophila pneumonia induces neutrophil recruitment to the lung through CXC chemokines. Previously, blocking CXCR2, the common receptor for CXC chemokines, but not CXCL1 or CXCL2, resulted in attenuated neutrophil accumulation and reduced survival following pulmonary L. pneumophila infection. However, gene-deficient mice were unavailable at that time and therefore, mechanisms of host protection and neutrophil homeostasis, including granulopoiesis and neutrophil release from the bone marrow, have not been investigated. Here, we delineated the role of CXCL1 and CXCL2 in host defense and neutrophil homeostasis using gene-deficient mice. Deficiency of CXCL1, but not CXCL2, impairs bacterial clearance and neutrophil accumulation in the lung. Furthermore, the increase of IL-18 and IFN-γ proteins in the lung caused by L. pneumophila infection is decreased in Cxcl1−/− mice. Moreover, this reduction in IFN-γ production in Cxcl1−/− mice is associated with a decrease in the γδTCR-expressing IFN-γ+ subset. In vivo treatment with IL-18 or IFN-γ was found to restore neutrophil-dependent bacterial clearance in Cxcl1−/− mice. Production of CXCL1 not only by hematopoietic cells, but also by nonhematopoietic cells, is critical to augment host defense. In Cxcl1−/− mice, there is an impairment in emergency granulopoiesis in bone marrow and in neutrophil release to the blood. Also, Il-18−/− mice displayed impairment of neutrophil recruitment to the lung and bacterial clearance, neutrophil release, and emergency granulopoiesis. Collectively, CXCL1 derived from both hematopoietic and nonhematopoietic cells is essential to control L. pneumophila infection through the IL-18–IFN-γ axis and neutrophil homeostasis.
- 8 August 2025
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 214 (11) , 3043-3054
CXCL1 augments host defense against Legionella pneumophila through the IL-18–IFN-γ axis and neutrophil homeostasis
Legionella pneumophila causes severe pneumonia, resulting in acute lung injury. L. pneumophila pneumonia induces neutrophil recruitment to the lung through CXC chemokines. Previously, blocking CXCR2, the common receptor for CXC chemokines, but not CXCL1 or CXCL2, resulted in attenuated neutrophil accumulation and reduced survival following pulmonary L. pneumophila infection. However, gene-deficient mice were unavailable at that time and therefore, mechanisms of host protection and neutrophil homeostasis, including granulopoiesis and neutrophil release from the bone marrow, have not been investigated. Here, we delineated the role of CXCL1 and CXCL2 in host defense and neutrophil homeostasis using gene-deficient mice. Deficiency of CXCL1, but not CXCL2, impairs bacterial clearance and neutrophil accumulation in the lung. Furthermore, the increase of IL-18 and IFN-γ proteins in the lung caused by L. pneumophila infection is decreased in Cxcl1−/− mice. Moreover, this reduction in IFN-γ production in Cxcl1−/− mice is associated with a decrease in the γδTCR-expressing IFN-γ+ subset. In vivo treatment with IL-18 or IFN-γ was found to restore neutrophil-dependent bacterial clearance in Cxcl1−/− mice. Production of CXCL1 not only by hematopoietic cells, but also by nonhematopoietic cells, is critical to augment host defense. In Cxcl1−/− mice, there is an impairment in emergency granulopoiesis in bone marrow and in neutrophil release to the blood. Also, Il-18−/− mice displayed impairment of neutrophil recruitment to the lung and bacterial clearance, neutrophil release, and emergency granulopoiesis. Collectively, CXCL1 derived from both hematopoietic and nonhematopoietic cells is essential to control L. pneumophila infection through the IL-18–IFN-γ axis and neutrophil homeostasis.
- Open Access
- 1 August 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 73 (2) , 178-199
Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report
The global incidence of respiratory infectious diseases caused by bacteria continues to increase, with acute lower respiratory tract infections contributing to significant morbidity and mortality. Preclinical models designed to investigate such respiratory bacterial diseases are of utmost importance to decipher their pathogenesis and develop novel targets for intervention and treatment. Animal models offer the powerful ability to investigate different pneumonia types at varying stages of infection and disease. However, the same models can promote important variations in outcome, potentially confounding scientific understanding in the field. Therefore, an expert panel was convened to deliberate best practices in animal models of bacterial pneumonia to identify validated methodologies and acknowledge limitations in the use of animal and non-animal models in this field of study. Herein, we summarize this American Thoracic Society workshop on animal models of bacterial pneumonia. This workshop further includes review of non-animal complementary or alternative models for studying bacterial pneumonia. Emphasis was placed on discussion of bacterial pathogens that frequently cause community- and hospital-acquired pneumonia, highlighting key aspects in modeling infection. Animal models discussed included small and large animals, based on their strengths. Finally and most importantly, the ethical considerations in the use of animal modeling for the study of bacterial lung infections was discussed. This workshop report is intended to provide insights to investigators in the field and may serve as a starting point for formal recommendations in the future.
- 1 August 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 73 (2) , 178-199
Open AccessBest Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report
The global incidence of respiratory infectious diseases caused by bacteria continues to increase, with acute lower respiratory tract infections contributing to significant morbidity and mortality. Preclinical models designed to investigate such respiratory bacterial diseases are of utmost importance to decipher their pathogenesis and develop novel targets for intervention and treatment. Animal models offer the powerful ability to investigate different pneumonia types at varying stages of infection and disease. However, the same models can promote important variations in outcome, potentially confounding scientific understanding in the field. Therefore, an expert panel was convened to deliberate best practices in animal models of bacterial pneumonia to identify validated methodologies and acknowledge limitations in the use of animal and non-animal models in this field of study. Herein, we summarize this American Thoracic Society workshop on animal models of bacterial pneumonia. This workshop further includes review of non-animal complementary or alternative models for studying bacterial pneumonia. Emphasis was placed on discussion of bacterial pathogens that frequently cause community- and hospital-acquired pneumonia, highlighting key aspects in modeling infection. Animal models discussed included small and large animals, based on their strengths. Finally and most importantly, the ethical considerations in the use of animal modeling for the study of bacterial lung infections was discussed. This workshop report is intended to provide insights to investigators in the field and may serve as a starting point for formal recommendations in the future.
- 4 July 2025
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
Neutrophil CD300ld: A savior of organ failure?
Discussion on the role of CD300ld-mediated phagocytosis by neutrophils in the context of organ damage in sepsis.
- 4 July 2025
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
Neutrophil CD300ld: A savior of organ failure?
Discussion on the role of CD300ld-mediated phagocytosis by neutrophils in the context of organ damage in sepsis.
- Open Access
- 16 August 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1249098
Role of toll-like receptors and nod-like receptors in acute lung infection
The respiratory system exposed to microorganisms continuously, and the pathogenicity of these microbes not only contingent on their virulence factors, but also the host’s immunity. A multifaceted innate immune mechanism exists in the respiratory tract to cope with microbial infections and to decrease tissue damage. The key cell types of the innate immune response are macrophages, neutrophils, dendritic cells, epithelial cells, and endothelial cells. Both the myeloid and structural cells of the respiratory system sense invading microorganisms through binding or activation of pathogen-associated molecular patterns (PAMPs) to pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs). The recognition of microbes and subsequent activation of PRRs triggers a signaling cascade that leads to the activation of transcription factors, induction of cytokines/5chemokines, upregulation of cell adhesion molecules, recruitment of immune cells, and subsequent microbe clearance. Since numerous microbes resist antimicrobial agents and escape innate immune defenses, in the future, a comprehensive strategy consisting of newer vaccines and novel antimicrobials will be required to control microbial infections. This review summarizes key findings in the area of innate immune defense in response to acute microbial infections in the lung. Understanding the innate immune mechanisms is critical to design host-targeted immunotherapies to mitigate excessive inflammation while controlling microbial burden in tissues following lung infection.
- 16 August 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1249098
Open AccessRole of toll-like receptors and nod-like receptors in acute lung infection
The respiratory system exposed to microorganisms continuously, and the pathogenicity of these microbes not only contingent on their virulence factors, but also the host’s immunity. A multifaceted innate immune mechanism exists in the respiratory tract to cope with microbial infections and to decrease tissue damage. The key cell types of the innate immune response are macrophages, neutrophils, dendritic cells, epithelial cells, and endothelial cells. Both the myeloid and structural cells of the respiratory system sense invading microorganisms through binding or activation of pathogen-associated molecular patterns (PAMPs) to pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs). The recognition of microbes and subsequent activation of PRRs triggers a signaling cascade that leads to the activation of transcription factors, induction of cytokines/5chemokines, upregulation of cell adhesion molecules, recruitment of immune cells, and subsequent microbe clearance. Since numerous microbes resist antimicrobial agents and escape innate immune defenses, in the future, a comprehensive strategy consisting of newer vaccines and novel antimicrobials will be required to control microbial infections. This review summarizes key findings in the area of innate immune defense in response to acute microbial infections in the lung. Understanding the innate immune mechanisms is critical to design host-targeted immunotherapies to mitigate excessive inflammation while controlling microbial burden in tissues following lung infection.
- Top Cited PapersOpen Access
- 5 September 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 961601
Regulation of emergency granulopoiesis during infection
During acute infectious and inflammatory conditions, a large number of neutrophils are in high demand as they are consumed in peripheral organs. The hematopoietic system rapidly responds to the demand by turning from steady state to emergency granulopoiesis to expedite neutrophil generation in the bone marrow (BM). How the hematopoietic system integrates pathogenic and inflammatory stress signals into the molecular cues of emergency granulopoiesis has been the subject of investigations. Recent studies in the field have highlighted emerging concepts, including the direct sensing of pathogens by BM resident or sentinel hematopoietic stem and progenitor cells (HSPCs), the crosstalk of HSPCs, endothelial cells, and stromal cells to convert signals to granulopoiesis, and the identification of novel inflammatory molecules, such as C/EBP-β, ROS, IL-27, IFN-γ, CXCL1 with direct effects on HSPCs. In this review, we will provide a detailed account of emerging concepts while reassessing well-established cellular and molecular players of emergency granulopoiesis. While providing our views on the discrepant results and theories, we will postulate an updated model of granulopoiesis in the context of health and disease.
- 5 September 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 961601
Top Cited PapersOpen AccessRegulation of emergency granulopoiesis during infection
During acute infectious and inflammatory conditions, a large number of neutrophils are in high demand as they are consumed in peripheral organs. The hematopoietic system rapidly responds to the demand by turning from steady state to emergency granulopoiesis to expedite neutrophil generation in the bone marrow (BM). How the hematopoietic system integrates pathogenic and inflammatory stress signals into the molecular cues of emergency granulopoiesis has been the subject of investigations. Recent studies in the field have highlighted emerging concepts, including the direct sensing of pathogens by BM resident or sentinel hematopoietic stem and progenitor cells (HSPCs), the crosstalk of HSPCs, endothelial cells, and stromal cells to convert signals to granulopoiesis, and the identification of novel inflammatory molecules, such as C/EBP-β, ROS, IL-27, IFN-γ, CXCL1 with direct effects on HSPCs. In this review, we will provide a detailed account of emerging concepts while reassessing well-established cellular and molecular players of emergency granulopoiesis. While providing our views on the discrepant results and theories, we will postulate an updated model of granulopoiesis in the context of health and disease.
- 21 April 2022
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 90 (4) , e0001422
Correction for Jeyaseelan et al., “Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury”
- 21 April 2022
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 90 (4) , e0001422
Correction for Jeyaseelan et al., “Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury”
- 15 August 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 207 (4) , 1112-1127
Host Defense against Klebsiella pneumoniae Pneumonia Is Augmented by Lung-Derived Mesenchymal Stem Cells
Klebsiella pneumoniae is a common cause of Gram-negative pneumonia. The spread of antibiotic-resistant and hypervirulent strains has made treatment more challenging. This study sought to determine the immunomodulatory, antibacterial, and therapeutic potential of purified murine stem cell Ag-1+ (Sca-1+) lung mesenchymal stem cells (LMSCs) using in vitro cell culture and an in vivo mouse model of pneumonia caused by K. pneumoniae. Sca-1+ LMSCs are plastic adherent, possess colony-forming capacity, express mesenchymal stem cell markers, differentiate into osteogenic and adipogenic lineages in vitro, and exhibit a high proliferative capacity. Further, these Sca-1+ LMSCs are morphologically similar to fibroblasts but differ ultrastructurally. Moreover, Sca-1+ LMSCs have the capacity to inhibit LPS-induced secretion of inflammatory cytokines by bone marrow–derived macrophages and neutrophils in vitro. Sca-1+ LMSCs inhibit the growth of K. pneumoniae more potently than do neutrophils. Sca-1+ LMSCs also possess the intrinsic ability to phagocytize and kill K. pneumoniae intracellularly. Whereas the induction of autophagy promotes bacterial replication, inhibition of autophagy enhances the intracellular clearance of K. pneumoniae in Sca-1+ LMSCs during the early time of infection. Adoptive transfer of Sca-1+ LMSCs in K. pneumoniae–infected mice improved survival, reduced inflammatory cells in bronchoalveolar lavage fluid, reduced inflammatory cytokine levels and pathological lesions in the lung, and enhanced bacterial clearance in the lung and in extrapulmonary organs. To our knowledge, these results together illustrate for the first time the protective role of LMSCs in bacterial pneumonia. Key Points A homogeneous population of LMSCs is purified from mouse lungs using Sca-1. LMSCs modulate neutrophil and macrophage functions and show bacterial killing. LMSCs improve survival, minimize inflammation, and enhance bacterial clearance.
- 15 August 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 207 (4) , 1112-1127
Host Defense against Klebsiella pneumoniae Pneumonia Is Augmented by Lung-Derived Mesenchymal Stem Cells
Klebsiella pneumoniae is a common cause of Gram-negative pneumonia. The spread of antibiotic-resistant and hypervirulent strains has made treatment more challenging. This study sought to determine the immunomodulatory, antibacterial, and therapeutic potential of purified murine stem cell Ag-1+ (Sca-1+) lung mesenchymal stem cells (LMSCs) using in vitro cell culture and an in vivo mouse model of pneumonia caused by K. pneumoniae. Sca-1+ LMSCs are plastic adherent, possess colony-forming capacity, express mesenchymal stem cell markers, differentiate into osteogenic and adipogenic lineages in vitro, and exhibit a high proliferative capacity. Further, these Sca-1+ LMSCs are morphologically similar to fibroblasts but differ ultrastructurally. Moreover, Sca-1+ LMSCs have the capacity to inhibit LPS-induced secretion of inflammatory cytokines by bone marrow–derived macrophages and neutrophils in vitro. Sca-1+ LMSCs inhibit the growth of K. pneumoniae more potently than do neutrophils. Sca-1+ LMSCs also possess the intrinsic ability to phagocytize and kill K. pneumoniae intracellularly. Whereas the induction of autophagy promotes bacterial replication, inhibition of autophagy enhances the intracellular clearance of K. pneumoniae in Sca-1+ LMSCs during the early time of infection. Adoptive transfer of Sca-1+ LMSCs in K. pneumoniae–infected mice improved survival, reduced inflammatory cells in bronchoalveolar lavage fluid, reduced inflammatory cytokine levels and pathological lesions in the lung, and enhanced bacterial clearance in the lung and in extrapulmonary organs. To our knowledge, these results together illustrate for the first time the protective role of LMSCs in bacterial pneumonia. Key Points A homogeneous population of LMSCs is purified from mouse lungs using Sca-1. LMSCs modulate neutrophil and macrophage functions and show bacterial killing. LMSCs improve survival, minimize inflammation, and enhance bacterial clearance.